The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Drug use
Adverse effects
Clinical status
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.